Environmental, Social & Governance Report

Overview

The report presents Pfizer's 2022 ESG priorities and progress across environment, social, and governance. It reports an 11.2% reduction in Scope 1 and 2 emissions from 2019, a 7.8% renewable electricity share, and a 2040 Net-Zero ambition. It also highlights more than 1.3 billion patients treated or vaccinated, women's representation of 43.1% at VP+ levels, and four women among 12 board members. The report includes GRI, SASB and TCFD disclosures, detailed KPI tables, and limited assurance of certain GHG data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview